Comparing DNA methylation profiles in saliva and intestinal mucosa

Nerissa L. Hearn, Aaron S. Coleman, Vincent Ho, Christine L. Chiu, Joanne M. Lind

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Altered epigenetic profiles are a feature of intestinal diseases, including ulcerative colitis and Crohn's disease. DNA methylation studies in these diseases have utilised intestinal mucosal tissue or blood which can be difficult to collect, particularly for large-scale research studies. Saliva is an attractive alternative for epigenetic studies as it is easy to collect and provides high quality methylation profiles. The aim of the study was to determine the utility of saliva as an alternative for DNA methylation studies of intestinal disorders. Results: DNA methylation in saliva and intestinal mucosa samples were compared in individuals (n = 10) undergoing endoscopies using the Illumina Infinium Methylation 450 K Beadchip array. We found that DNA methylation was correlated between tissue types within an individual (Pearson correlation co-efficient r = 0.92 to 0.95, p < 0.001). Of the 48,541 probes (approximately 11% of CpG sites) that were differentially methylated between saliva and intestinal mucosa (adjusted p < 0.001, |Δβ| ≥ 20%), these mapped to genes involved in tissue-specific pathways, including the apelin signalling and oxytocin pathways which are important in gastrointestinal cytoprotection and motility. Conclusions: This study suggests that saliva has the potential to be used as an alternate DNA source to invasive intestinal mucosa for DNA methylation research into intestinal conditions.

LanguageEnglish
Article number163
Pages1-9
Number of pages9
JournalBMC Genomics
Volume20
Issue number1
DOIs
Publication statusPublished - 28 Feb 2019

Fingerprint

DNA Methylation
Intestinal Mucosa
Saliva
Epigenomics
Methylation
Intestinal Diseases
Gastrointestinal Motility
Cytoprotection
Oxytocin
Ulcerative Colitis
Research
Crohn Disease
Endoscopy
Mucous Membrane
DNA
Genes

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Cite this

Hearn, Nerissa L. ; Coleman, Aaron S. ; Ho, Vincent ; Chiu, Christine L. ; Lind, Joanne M. / Comparing DNA methylation profiles in saliva and intestinal mucosa. In: BMC Genomics. 2019 ; Vol. 20, No. 1. pp. 1-9.
@article{9d771906692f475c9617182e7f36aa64,
title = "Comparing DNA methylation profiles in saliva and intestinal mucosa",
abstract = "Background: Altered epigenetic profiles are a feature of intestinal diseases, including ulcerative colitis and Crohn's disease. DNA methylation studies in these diseases have utilised intestinal mucosal tissue or blood which can be difficult to collect, particularly for large-scale research studies. Saliva is an attractive alternative for epigenetic studies as it is easy to collect and provides high quality methylation profiles. The aim of the study was to determine the utility of saliva as an alternative for DNA methylation studies of intestinal disorders. Results: DNA methylation in saliva and intestinal mucosa samples were compared in individuals (n = 10) undergoing endoscopies using the Illumina Infinium Methylation 450 K Beadchip array. We found that DNA methylation was correlated between tissue types within an individual (Pearson correlation co-efficient r = 0.92 to 0.95, p < 0.001). Of the 48,541 probes (approximately 11{\%} of CpG sites) that were differentially methylated between saliva and intestinal mucosa (adjusted p < 0.001, |Δβ| ≥ 20{\%}), these mapped to genes involved in tissue-specific pathways, including the apelin signalling and oxytocin pathways which are important in gastrointestinal cytoprotection and motility. Conclusions: This study suggests that saliva has the potential to be used as an alternate DNA source to invasive intestinal mucosa for DNA methylation research into intestinal conditions.",
keywords = "DNA methylation, Intestinal mucosal, Saliva",
author = "Hearn, {Nerissa L.} and Coleman, {Aaron S.} and Vincent Ho and Chiu, {Christine L.} and Lind, {Joanne M.}",
note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "2",
day = "28",
doi = "10.1186/s12864-019-5553-0",
language = "English",
volume = "20",
pages = "1--9",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "Springer, Springer Nature",
number = "1",

}

Comparing DNA methylation profiles in saliva and intestinal mucosa. / Hearn, Nerissa L.; Coleman, Aaron S.; Ho, Vincent; Chiu, Christine L.; Lind, Joanne M.

In: BMC Genomics, Vol. 20, No. 1, 163, 28.02.2019, p. 1-9.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Comparing DNA methylation profiles in saliva and intestinal mucosa

AU - Hearn,Nerissa L.

AU - Coleman,Aaron S.

AU - Ho,Vincent

AU - Chiu,Christine L.

AU - Lind,Joanne M.

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/2/28

Y1 - 2019/2/28

N2 - Background: Altered epigenetic profiles are a feature of intestinal diseases, including ulcerative colitis and Crohn's disease. DNA methylation studies in these diseases have utilised intestinal mucosal tissue or blood which can be difficult to collect, particularly for large-scale research studies. Saliva is an attractive alternative for epigenetic studies as it is easy to collect and provides high quality methylation profiles. The aim of the study was to determine the utility of saliva as an alternative for DNA methylation studies of intestinal disorders. Results: DNA methylation in saliva and intestinal mucosa samples were compared in individuals (n = 10) undergoing endoscopies using the Illumina Infinium Methylation 450 K Beadchip array. We found that DNA methylation was correlated between tissue types within an individual (Pearson correlation co-efficient r = 0.92 to 0.95, p < 0.001). Of the 48,541 probes (approximately 11% of CpG sites) that were differentially methylated between saliva and intestinal mucosa (adjusted p < 0.001, |Δβ| ≥ 20%), these mapped to genes involved in tissue-specific pathways, including the apelin signalling and oxytocin pathways which are important in gastrointestinal cytoprotection and motility. Conclusions: This study suggests that saliva has the potential to be used as an alternate DNA source to invasive intestinal mucosa for DNA methylation research into intestinal conditions.

AB - Background: Altered epigenetic profiles are a feature of intestinal diseases, including ulcerative colitis and Crohn's disease. DNA methylation studies in these diseases have utilised intestinal mucosal tissue or blood which can be difficult to collect, particularly for large-scale research studies. Saliva is an attractive alternative for epigenetic studies as it is easy to collect and provides high quality methylation profiles. The aim of the study was to determine the utility of saliva as an alternative for DNA methylation studies of intestinal disorders. Results: DNA methylation in saliva and intestinal mucosa samples were compared in individuals (n = 10) undergoing endoscopies using the Illumina Infinium Methylation 450 K Beadchip array. We found that DNA methylation was correlated between tissue types within an individual (Pearson correlation co-efficient r = 0.92 to 0.95, p < 0.001). Of the 48,541 probes (approximately 11% of CpG sites) that were differentially methylated between saliva and intestinal mucosa (adjusted p < 0.001, |Δβ| ≥ 20%), these mapped to genes involved in tissue-specific pathways, including the apelin signalling and oxytocin pathways which are important in gastrointestinal cytoprotection and motility. Conclusions: This study suggests that saliva has the potential to be used as an alternate DNA source to invasive intestinal mucosa for DNA methylation research into intestinal conditions.

KW - DNA methylation

KW - Intestinal mucosal

KW - Saliva

UR - http://www.scopus.com/inward/record.url?scp=85062360085&partnerID=8YFLogxK

U2 - 10.1186/s12864-019-5553-0

DO - 10.1186/s12864-019-5553-0

M3 - Article

VL - 20

SP - 1

EP - 9

JO - BMC Genomics

T2 - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

IS - 1

M1 - 163

ER -